Technology Transfer From Biomedical Research to Clinical Practice: Measuring Innovation Performance

Evaluation and the Health Professions

Volumn 36, Issue 4, 2013, Pages 505-517

  Balas, E Andrew ^a   Elkin, Peter L ^b  

^a AUGUSTA UNIVERSITY   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

biomedical innovation; CTSA; performance improvement; quality measures; technology transfer; translational research

Indexed keywords

ARTICLE; BIOMEDICAL INNOVATION; CLINICAL TRIAL (TOPIC); CTSA; ECONOMICS; HUMAN; MASS COMMUNICATION; NATIONAL HEALTH ORGANIZATION; PATENT; PERFORMANCE IMPROVEMENT; PROGRAM EVALUATION; QUALITY MEASURES; STATISTICAL MODEL; TECHNOLOGY; TOTAL QUALITY MANAGEMENT; TRANSLATIONAL RESEARCH; UNITED STATES;

BIOMEDICAL INNOVATION; CTSA; PERFORMANCE IMPROVEMENT; QUALITY MEASURES; TECHNOLOGY TRANSFER; TRANSLATIONAL RESEARCH;

CLINICAL TRIALS AS TOPIC; DIFFUSION OF INNOVATION; HUMANS; INTELLECTUAL PROPERTY; MODELS, ECONOMIC; NATIONAL INSTITUTES OF HEALTH (U.S.); PROGRAM EVALUATION; QUALITY IMPROVEMENT; TECHNOLOGY TRANSFER; TRANSLATIONAL MEDICAL RESEARCH; UNITED STATES;

EID: 84887432778     PISSN: 01632787     EISSN: 15523918     Source Type: Journal    
DOI: 10.1177/0163278713508135     Document Type: Article

References (17)

1. Adelman D. E.,DeAngelis K. L.Patent Metrics: The mismeasure of innovation in the biotech patent debate.Texas Law Review. 2007;85:1677-1744.
2. Advisory Committee on Measuring Innovation in the 21st Century Economy, Department of Commerce. (2008). Innovation measurement: Tracking the state of innovation in the American economy. A report to the secretary of commerce. Retrieved fromwww.innovationmetrics.gov.
3. Anthony S. D.,Johnson M. W.,Sinfield J. V.,Altman E. J.Innovation metrics. Boston, MA: Harvard business press; 2008:.
4. Association of American Universities. (2013, July). Association of Public and Land-Grant Universities. Letter to Pres. Obama & Members of the 113th Congress. Retrieved fromwww.innovationdeficit.org.
5. Association of University Technology Managers. 2011 U.S. and Canadian licensing activity surveys. Deerfield, IL: Author; 2012:.
6. Balas E. A.,Boren S. A.Yearbook of medical informatics 2000: Patient-centered systems. Bemmel J.McCray A. T., ed. Stuttgart, Germany: Schattauer Verlagsgesellschaft mbH; 2000:65-70.
7. The diabetes control and complications trial (DCCT).The New England Journal of Medicine. 1993;329:977-86.
8. Drucker P.Management: Tasks, responsibilities, practices. New York, NY: Harper & Row; 1974:.
9. Eesley C. E.,Miller W. F.Impact: Stanford University's economic impact via innovation and entrepreneurship. Stanford, CA: Stanford University Press; 2012:.
10. Grimshaw J. M.,Eccles M. P.,Lavis J. N.,Hill S. J.,Squires J. E.Knowledge translation of research findings.Implementation Science. 2012;7:50.
11. Jensen R. A.,Thursby M. C.Proofs and prototypes for sale: The licensing of university inventions.The American Economic Review. 2001;91:240-259.
12. Leshner A.,Terry S. F.,Schultz A. M.,Liverman C. T.The CTSA program at NIH: Opportunities for advancing clinical and translational research. Washington, DC: IOM Press; 2013:.
13. Advancing measures of innovation: Knowledge flows, business metrics, and measurement strategies. Arlington, VA: Author; 2007:.
14. Porter M.,van der Linde C.Toward a new conception of the environment-competitiveness relationship.Journal of Economic Perspective. 1995;9:97-118.
15. Report to the president on propelling innovation in drug discovery, development, and evaluation. Washington, DC: Author; 2012:.
16. Roberts E. B.,Charles Eesley C.Entrepreneurial impact: The role of MIT. Cambridge, MA: Ewing Marion Kauffman Foundation; 2009:.
17. Smith K. H.The Oxford Handbook of Innovation. New York, US: Oxford University Press; 2005:148-177.